Elevated serum soluble CD226 levels are observed in active systemic lupus erythematosus and correlate with disease activity indices and anti-dsDNA antibody titers, positioning soluble CD226 as a biomarker to monitor disease flares [86]. This evidence concerns the gene CD226 and systemic lupus erythematosus.